http://purl.org/np/RASJaMbKa-... RASJaMbKa-

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

0000-0002-7641-6446

2021-05-25T12:46:33.571Z

http://purl.org/np/RASJaMbKa-... RASJaMbKa-

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

The most commonly reported diagnosis treated was Major Depressive Disorder (72.2%), followed by Bipolar Disorder (15.1%), and Posttraumatic Stress Disorder (5.7%). Most providers (87.7%) reported administering ketamine via an intravenous route, with a minority reporting using an oral (22.8%) or an intranasal (19.3%) formulation.

0000-0002-7641-6446

2021-05-25T12:46:33.571Z

http://purl.org/np/RASJaMbKa-... RASJaMbKa-

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/MONDO_0004985 MONDO_0004985

0000-0002-7641-6446

2021-05-25T12:46:33.571Z

http://purl.org/np/RASJaMbKa-... RASJaMbKa-

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

0000-0002-7641-6446

2021-05-25T12:46:33.571Z

http://purl.org/np/RASJaMbKa-... RASJaMbKa-

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://go.drugbank.com/drugs/DB01221 DB01221

0000-0002-7641-6446

2021-05-25T12:46:33.571Z

http://purl.org/np/RASJaMbKa-... RASJaMbKa-

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/has_population_context has_population_context

http://purl.org/np/RASJaMbKa-...#cohort cohort

0000-0002-7641-6446

2021-05-25T12:46:33.571Z

http://purl.org/np/RASJaMbKa-... RASJaMbKa-

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/publications publications

https://pubmed.ncbi.nlm.nih.gov/28669202/ pubmed.ncbi.nlm.nih.gov/28669202

0000-0002-7641-6446

2021-05-25T12:46:33.571Z

http://purl.org/np/RASJaMbKa-... RASJaMbKa-

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/association_type association_type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

0000-0002-7641-6446

2021-05-25T12:46:33.571Z

http://purl.org/np/RASJaMbKa-... RASJaMbKa-

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

0000-0002-7641-6446

2021-05-25T12:46:33.571Z

http://purl.org/np/RASJaMbKa-... RASJaMbKa-

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://w3id.org/um/neurodkg/OffLabelIndication OffLabelIndication

0000-0002-7641-6446

2021-05-25T12:46:33.571Z